Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.56 is 69% below its 5-year average of 1.82, near the low end of its 5-year range (0.55–6.13).
As of the fiscal period ended Tuesday, June 30, 2026. 56.46% below its 12-month average of 1.28.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.56.
QUICK RATIO (ACID-TEST)
0.56
QUICK RATIO (ACID-TEST) AVG TTM
1.28
QUICK RATIO (ACID-TEST) AVG 3Y
1.33
QUICK RATIO (ACID-TEST) AVG 5Y
1.82
QUICK RATIO (ACID-TEST) AVG 10Y
2.97
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-56.46%
CURRENT VS 3Y AVG
-58.05%
CURRENT VS 5Y AVG
-69.39%
CURRENT VS 10Y AVG
-81.22%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-83.38%
vs the sector median at left
Market Cap
$6.87M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$6.77M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$6.70M
Quick Ratio (Acid-Test)
N/A
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.05
Market Cap
$6.95M
Quick Ratio (Acid-Test)
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.52
Market Cap
$6.67M
Quick Ratio (Acid-Test)
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
Market Cap
$6.57M
Quick Ratio (Acid-Test)
16.20
TTM Avg
7.76
3Y Avg
4.60
5Y Avg
3.08
Market Cap
$7.03M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.82M | 0.56 | 1.28 | 1.33 | 1.82 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.87M | 2.61 | 3.40 | 4.86 | 5.09 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.77M | 45.95 | 58.73 | 40.89 | 40.89 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.70M | N/A | 2.00 | 1.31 | 1.05 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.95M | 0.31 | 1.26 | 1.91 | 5.52 |
| KALA BIO, Inc. (KALA)vs › | $6.96M | 6.88 | 3.46 | 4.15 | 4.53 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.67M | 10.21 | 3.61 | 3.34 | 4.20 |
| Aclarion, Inc. (ACON)vs › | $6.57M | 16.20 | 7.76 | 4.60 | 3.08 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.03M | 1.52 | 3.93 | 10.24 | 10.80 |
| Biomerica, Inc. (BMRA)vs › | $6.54M | 0.93 | 1.44 | 2.71 | 3.16 |
Quick Ratio
0.56
Excludes inventory
Current Ratio
0.56
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.56 |
| 2026-03-31 | 0.79 |
| 2025-12-31 | 1.19 |
| 2025-09-30 | 1.96 |
| 2025-06-30 | 1.89 |
| 2025-03-31 | 2.91 |
| 2024-12-31 | 4.45 |
| 2024-09-30 | 0.71 |
| 2024-06-30 | 0.61 |
| 2024-03-31 | 0.55 |
| 2023-12-31 | 0.81 |
| 2023-09-30 | 1.39 |
| 2023-06-30 | 2.56 |
| 2023-03-31 | 4.13 |
| 2022-12-31 | 6.13 |
| 2022-09-30 | 0.67 |
| 2022-06-30 | 1.26 |
| 2022-03-31 | 1.37 |
| 2021-12-31 | 1.28 |
| 2021-09-30 | 2.82 |
| 2021-06-30 | 4.47 |
| 2021-03-31 | 5.40 |
| 2020-12-31 | 6.29 |
| 2020-09-30 | 7.58 |
| 2020-06-30 | 6.05 |
| 2020-03-31 | 4.92 |
| 2019-12-31 | 3.63 |
| 2019-09-30 | 8.59 |
| 2019-06-30 | 2.20 |
| 2019-03-31 | 2.77 |
| 2018-12-31 | 13.22 |
| 2018-09-30 | 3.69 |
| 2018-06-30 | 4.24 |
| 2018-03-31 | 7.64 |
| 2017-12-31 | 8.24 |
| 2017-09-30 | 2.31 |
| 2017-06-30 | 0.93 |
| 2017-04-01 | 0.00 |
| 2016-12-31 | 1.65 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
